BRIEF published on 09/24/2024 at 18:05, 6 months 12 days ago Sightview Software Announces Inaugural 'Sightview Summit 2025' Continuing Education Eye Care Software Sightview Summit 2025 Customer Conference New Orleans
BRIEF published on 09/24/2024 at 18:05, 6 months 12 days ago Sightview Software annonce le premier « Sightview Summit 2025 » Formation Continue Logiciel De Soins Oculaires Sommet Sightview 2025 Conférence Client La Nouvelle-Orléans
PRESS RELEASE published on 09/24/2024 at 18:00, 6 months 12 days ago Sightview Software Announces Inaugural 'Sightview Summit 2025' Customer Conference Sightview Software to host inaugural customer conference, Sightview Summit 2025, in New Orleans on March 14-16, 2025. Event focuses on education, innovation, and community in eye care industry Innovation Education Eye Care Sightview Software Customer Conference
BRIEF published on 07/31/2024 at 15:05, 8 months 6 days ago Sightview Software Takes Over Eye Care Leaders, Commits to Product Investments Acquisition Investment User Conference Branding Eye Care Software
BRIEF published on 07/31/2024 at 15:05, 8 months 6 days ago Sightview Software reprend les leaders des soins oculaires et s'engage dans des investissements dans les produits Acquisition Investissement Conférence Des Utilisateurs L'image De Marque Logiciel De Soins Oculaires
PRESS RELEASE published on 07/31/2024 at 15:00, 8 months 6 days ago Following Sale to New Owners, Eye Care Leaders Becomes Sightview Software and Commits Additional Investment to All Products Eye Care Leaders rebrands to Sightview Software after sale to new owners, committing resources to enhance products and services for eye care practices nationwide Rebrand Software Provider Eye Care Leaders Sightview Software Eye Care Practices
Published on 04/07/2025 at 13:30, 36 minutes ago Orogen Royalties Announces Mineral Resource and Reserve Update on Producing Ermitaño Royalty Including Initial Inferred Resource for the Navidad Vein
Published on 04/07/2025 at 13:00, 1 hour 6 minutes ago Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
Published on 04/07/2025 at 13:00, 1 hour 6 minutes ago Electric Metals' Long-standing, Integrated Domestic Manganese Strategy Validated by U.S. Policy Shift Aimed at Restoring American Industrial Independence
Published on 04/07/2025 at 13:00, 1 hour 6 minutes ago EON Resources Inc. Confirms Oil Sales Hedged at $70.00 per Barrel for the Rest of CY 2025
Published on 04/07/2025 at 12:30, 1 hour 36 minutes ago iFabric Corp Acquires Remaining 25% Stake in Markham Property and Signs New Banking Agreement
Published on 04/07/2025 at 13:00, 1 hour 6 minutes ago CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 1 hour 9 minutes ago PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 9 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 04/07/2025 at 11:44, 2 hours 21 minutes ago EQS-Adhoc: Rubean AG: Change in the Supervisory Board
Published on 04/07/2025 at 11:18, 2 hours 47 minutes ago Cerinnov Group: DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTES
Published on 04/07/2025 at 07:01, 7 hours 5 minutes ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 7 hours 5 minutes ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 18 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 18 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 19 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
